Skip to main content
×
×
Home
  • Print publication year: 2015
  • Online publication date: April 2015

187 - Herpes simplex viruses 1 and 2

from Part XXIII - Specific organisms: viruses
Summary

The virus

Herpesviruses are generally defined as large enveloped virions with an icosapentahedral nucleocapsid consisting of 162 capsomeres arranged around a double-stranded DNA core. The two antigenically distinct types of herpes simplex virus (HSV) are HSV-1 and HSV-2. Considerable homology exists between the HSV-1 and HSV-2 genomes, with most of the polypeptides specified by one viral type being antigenically related to polypeptides of the other viral type. Although this results in considerable cross-reactivity between the HSV-1 and HSV-2, glycoproteins G (gG) are unique antigenic determinants that allow for differentiation between these two viruses (e.g., gG-1 and gG-2). Surrounding the viral genome and nucleocapsid is a tightly adherent membrane known as the tegument. A lipid envelope containing the viral glycoproteins loosely surrounds the tegument.

Pathology and pathogenesis

Cutaneous HSV infection causes ballooning of infected epithelial cells, with nuclear degeneration, loss of intact cellular membranes, and the formation of multinucleated giant cells. Ultimately, cells lyse and release clear fluid containing large quantities of virus, with subsequent accumulation of cellular debris and inflammatory cells between the epidermal and dermal layers. Multinucleated giant cells are usually present at the base of the vesicle. An intense inflammatory response extends from the base of the vesicle into the dermis, producing the erythema that classically surrounds a cluster of HSV vesicles. As the lesions heal, vesicular fluid becomes purulent as more inflammatory cells are recruited to the site of infection. Scab formation then follows. Scarring is uncommon.

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Clinical Infectious Disease
  • Online ISBN: 9781139855952
  • Book DOI: https://doi.org/10.1017/CBO9781139855952
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×
Suggested reading
Kimberlin, DW. Neonatal herpes simplex infection. Clin Microbiol Rev. 2004;17(1):1–13.
Kimberlin, DW, Rouse, DJ. Genital herpes. N Engl J Med. 2004;350:1970–1977.
Kimberlin, DW, Whitley, RJ, Wan, W, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med. 2011;365(14):1284–1292.
Wald, A, Corey, L, Cone, R, et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J Clin Invest. 1997;99:1092–1097.
Whitley, RJ, Cobbs, CG, Alford, CA, et al. Diseases that mimic herpes simplex encephalitis: diagnosis, presentation, and outcome. JAMA. 1989;262:234–239.
Whitley, RJ, Kimberlin, DW, Roizman, B. Herpes simplex viruses. Clin Infect Dis. 1998;26:541–555.
Xu, F, Sternberg, MR, Kottiri, BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296:964–973.